Doebele Robert
Insider CIK 1856681 · RAIN See Remarks · BOLD Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BOLD Boundless Bio, Inc. | A Award deriv | 2026-01-23 | 2026-01-26 | 230,000 | — | $0 | 230,000 | SEC↗ |
| BOLD Boundless Bio, Inc. | A Award deriv | 2025-02-03 | 2025-02-03 | 180,000 | — | $0 | 180,000 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 59,642 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 1,981 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 9,260 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 49,700 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 99,400 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 9,260 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 112,206 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 13,890 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 5,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 12,358 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 90,620 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 11,119 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | U Tender | 2024-01-26 | 2024-01-26 | 476,827 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | A Award deriv | 2023-08-09 | 2023-08-11 | 99,400 | — | $0 | 99,400 | SEC↗ |
| RAIN Rain Oncology Inc. | A Award deriv | 2023-08-09 | 2023-08-11 | 49,700 | — | $0 | 49,700 | SEC↗ |
| RAIN Rain Oncology Inc. | A Award deriv | 2023-02-15 | 2023-02-17 | 123,325 | — | $0 | 123,325 | SEC↗ |
| RAIN Rain Therapeutics Inc. | M Exercise deriv | 2022-07-06 | 2022-07-07 | 3,890 | — | $0 | 5,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | M Exercise | 2022-07-06 | 2022-07-07 | 3,890 | $3.95 | $15.4K | 476,827 | SEC↗ |
| RAIN Rain Therapeutics Inc. | M Exercise deriv | 2022-04-13 | 2022-04-15 | 3,000 | — | $0 | 8,890 | SEC↗ |
| RAIN Rain Therapeutics Inc. | M Exercise | 2022-04-13 | 2022-04-15 | 3,000 | $3.95 | $11.8K | 472,937 | SEC↗ |
| RAIN Rain Therapeutics Inc. | M Exercise deriv | 2022-03-31 | 2022-04-04 | 2,000 | — | $0 | 11,890 | SEC↗ |
| RAIN Rain Therapeutics Inc. | M Exercise | 2022-03-31 | 2022-04-04 | 2,000 | $3.95 | $7.9K | 469,937 | SEC↗ |
| RAIN Rain Therapeutics Inc. | A Award deriv | 2022-01-07 | 2022-02-04 | 72,000 | — | $0 | 72,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 5,327 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion | 2021-04-27 | 2021-04-27 | 4,932 | — | $0 | 467,937 | SEC↗ |